• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

B+L launches peroxide-based lens solution

Article

Bausch + Lomb has introduced a new peroxide cleaning and disinfecting solution, PeroxiClear 3%.

 

Bridgewater, NJ-Bausch + Lomb has introduced a new peroxide cleaning and disinfecting solution, PeroxiClear 3%.

The new solution offers an alternative peroxide-based product, and has been proven to keep contact lenses cleaner and moister for longer, according to the company.

“We’ve been hearing from many doctors that there’s been an increasing need to address their patients’ contact lens discomfort,” said Josephy Barr, OD, MS, FAAP, vice president, medical affairs, pharmaceuticals and vision care, Bausch  + Lomb. “(The company) is proud to now provide an alternative option and innovation with (this solution).

“Bausch + Lomb’s mission has always been to help patients see better to live better, and with the introduction of (this) cleaning and disinfecting solution, we can now offer them the most advanced peroxide-based lens solution on the market today,” Barr continued.

The solution will be available in major retailers starting in April and May, including Target, Rite-Aid, K-Mart, Walmart, Walgreens, and CVS. It will be available at most retailers nationwide by June.

The solution was also presented during SECO last week, and will again be shown during Vision Expo East next week in New York City.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.